US Stock MarketDetailed Quotes

AGRX Agile Therapeutics

Watchlist
  • 0.415
  • +0.015+3.67%
15min DelayTrading Apr 25 10:29 ET
2.85MMarket Cap-61P/E (TTM)

Agile Therapeutics Key Stats

Agile Therapeutics Earnings Date

Currency: USD

Period

Q4 FY2023 Earnings

Mar 28, 2024

Revenue(YoY)

3.61M

-9.56%
EPS(YoY)

-1.41

+71.80%

Hold

Apr 23, 2024

Agile Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Mar 28, 20242023/Q43.615M / 4.069M--
Nov 9, 20232023/Q36.662M / 6.353M--
Aug 9, 20232023/Q25.503M / 4.627M--
May 11, 20232023/Q13.813M / 3.397M--
Mar 22, 20232022/Q43.996M / 3.125M--
--2022/Q33.002M / 2.334M--
Aug 11, 20222022/Q22.126M / 1.981M--
May 12, 20222022/Q11.761M / 1.224M--
Mar 30, 20222021/Q41.514M / 1.511M--
Nov 2, 20212021/Q31.287M / 1.462M--
DatePeriodRevenue/EstimateEarnings Call
Mar 28, 20242023/Q43.615M / 4.069M--
Nov 9, 20232023/Q36.662M / 6.353M--
Aug 9, 20232023/Q25.503M / 4.627M--
May 11, 20232023/Q13.813M / 3.397M--
Mar 22, 20232022/Q43.996M / 3.125M--
--2022/Q33.002M / 2.334M--
Aug 11, 20222022/Q22.126M / 1.981M--
May 12, 20222022/Q11.761M / 1.224M--
Mar 30, 20222021/Q41.514M / 1.511M--
Nov 2, 20212021/Q31.287M / 1.462M--

Unlock Free Earnings Estimates

Agile Therapeutics Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Apr 23, 2024

Hold

  • Buy

    0.00%
  • Hold

    100.00%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg